250 related articles for article (PubMed ID: 8614143)
1. Molecular genetic differentiation between primary lung cancers and lung metastases of other tumors.
Kandioler D; Dekan G; End A; Pasching E; Buchmayer H; Gnant M; Langmann F; Mannhalter C; Eckersberger F; Wolner E
J Thorac Cardiovasc Surg; 1996 Apr; 111(4):827-31; discussion 832. PubMed ID: 8614143
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.
Matsuzoe D; Hideshima T; Ohshima K; Kawahara K; Shirakusa T; Kimura A
Br J Cancer; 1999 Mar; 79(9-10):1549-52. PubMed ID: 10188905
[TBL] [Abstract][Full Text] [Related]
3. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
4. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene.
Tabor MP; van Houten VM; Kummer JA; Vosjan MJ; Vlasblom R; Snow GB; Leemans CR; Braakhuis BJ; Brakenhoff RH
Genes Chromosomes Cancer; 2002 Feb; 33(2):168-77. PubMed ID: 11793443
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations in matched primary and metastatic human tumors.
Peller S; Halevy A; Slutzki S; Kopilova Y; Rotter V
Mol Carcinog; 1995 Jul; 13(3):166-72. PubMed ID: 7619219
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis of lymph node micrometastases in human lung carcinoma: determination of p53 gene mutations by polymerase chain reaction-temperature gradient gel electrophoresis (PCR-TGGE)].
Xu ML; Wu BQ; Zhong HH; Yang X; Heng WJ
Ai Zheng; 2004 Jul; 23(7):794-8. PubMed ID: 15248914
[TBL] [Abstract][Full Text] [Related]
7. p53 mutations in primary human lung tumors and their metastases.
Reichel MB; Ohgaki H; Petersen I; Kleihues P
Mol Carcinog; 1994 Feb; 9(2):105-9. PubMed ID: 8142008
[TBL] [Abstract][Full Text] [Related]
8. Genetic diversity at the p53 locus between primary human colorectal adenocarcinomas and their lymph-node metastases.
Zhang JS; Caplin S; Bosman FT; Benhattar J
Int J Cancer; 1997 Mar; 70(6):674-8. PubMed ID: 9096648
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the P53 tumor suppressor gene as clonal marker for multiple primary lung cancers.
Mitsudomi T; Yatabe Y; Koshikawa T; Hatooka S; Shinoda M; Suyama M; Sugiura T; Ogawa M; Takahashi T
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):354-60. PubMed ID: 9305187
[TBL] [Abstract][Full Text] [Related]
10. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.
Kadivar M; Boozari B
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608
[TBL] [Abstract][Full Text] [Related]
11. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
[TBL] [Abstract][Full Text] [Related]
12. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.
Koch WM; Brennan JA; Zahurak M; Goodman SN; Westra WH; Schwab D; Yoo GH; Lee DJ; Forastiere AA; Sidransky D
J Natl Cancer Inst; 1996 Nov; 88(21):1580-6. PubMed ID: 8901856
[TBL] [Abstract][Full Text] [Related]
13. p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases.
Tjebbes GW; Leppers vd Straat FG; Tilanus MG; Hordijk GJ; Slootweg PJ
Oral Oncol; 1999 Jul; 35(4):384-9. PubMed ID: 10645403
[TBL] [Abstract][Full Text] [Related]
14. Recurrent TP53 missense mutation in cancer patients of Arab descent.
Zick A; Kadouri L; Cohen S; Frohlinger M; Hamburger T; Zvi N; Plaser M; Avital E; Breuier S; Elian F; Salah A; Goldberg Y; Peretz T
Fam Cancer; 2017 Apr; 16(2):295-301. PubMed ID: 27866339
[TBL] [Abstract][Full Text] [Related]
15. Targeted sequencing identifies the mutational signature of double primary and metastatic malignancies: a case report.
Rao C; Nie L; Miao X; Lizaso A; Zhao G
Diagn Pathol; 2019 Sep; 14(1):101. PubMed ID: 31484545
[TBL] [Abstract][Full Text] [Related]
16. p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma.
van Rens MT; Eijken EJ; Elbers JR; Lammers JW; Tilanus MG; Slootweg PJ
Cancer; 2002 Jan; 94(1):188-96. PubMed ID: 11815976
[TBL] [Abstract][Full Text] [Related]
17. [p53 gene mutation in cancer of the colon and rectum].
Roa JC; Roa I; Melo A; Araya JC; Villaseca MA; Flores M; Schneider B
Rev Med Chil; 2000 Sep; 128(9):996-1004. PubMed ID: 11349504
[TBL] [Abstract][Full Text] [Related]
18. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
19. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type.
Finkelstein SD; Sayegh R; Christensen S; Swalsky PA
Cancer; 1993 Jun; 71(12):3827-38. PubMed ID: 8508351
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine tumor metastasis to the thyroid gland.
Yamada H; Hasegawa Y; Mitsudomi T; Nakashima T; Yatabe Y
Int J Clin Oncol; 2007 Feb; 12(1):63-7. PubMed ID: 17380445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
